CAR T cells targeting the glycoprotein GD2 show potent antitumor efficacy in high-risk ependymoma models.

ABSTRACT: Aggressive pediatric brain tumor models of ependymoma are highly sensitive to GD2-directed (CAR T) cell therapy.

SUBMITTER: Tallon-Cobos AC 

PROVIDER: S-EPMC12807483 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature